BAVIS_1170x120_1-20

Daliresp

AstraZeneca buys Takeda respiratory business

AstraZeneca buys Takeda respiratory business

LONDON and OSAKA, Japan — AstraZeneca plans to acquire the core respiratory business of Takeda Pharmaceutical Co. Ltd. for $575 million. Under the agreement, approximately 200 Takeda staff will transfer to AstraZeneca after the closing of the transaction, expected in the first quarter of 2016. AstraZeneca said the deal will include the expansion of rights